FIELD: medicine.
SUBSTANCE: group of inventions refers to medicine, namely, oncology, and can be used to treat cutaneous T-cell lymphoma (CTCL). Methods of the invention comprise administering to a subject a therapeutically effective amount of a pharmaceutical composition, which included 0.03–0.06 by weight of 4-amino-α,α-dimethyl-2-ethoxymethyl-1H-imidazo[4,5-c]quinoline-1-ethanol (resiquimod) or a pharmaceutically acceptable salt thereof. Composition is applied to at least one CTCL lesion.
EFFECT: use of inventions makes it possible to treat CTCL by enhancing the cell-mediated immune response of a cell population that includes cells affected by CTCL to reduce the side effects of treatment.
20 cl, 3 dwg, 2 ex
| Title | Year | Author | Number |
|---|---|---|---|
| THERAPEUTIC USE OF THE TLR AGONIST AND COMBINED THERAPY | 2011 |
|
RU2603467C2 |
| YEAST-BASED IMMUNOTHERAPY FOR CHORDOMA | 2014 |
|
RU2679806C2 |
| APPLICATION OF NKG2D INHIBITORS FOR TREATING CARDIOVASCULAR AND METABOLIC DISEASES SUCH AS TYPE 2 DIABETES | 2010 |
|
RU2566264C2 |
| SYSTEM AND METHOD OF OBTAINING AND STORAGE OF ACTIVATED MATURE DENDRITIC CELLS | 2011 |
|
RU2575978C2 |
| PEGYLATED LIPOSOMES AND THEIR APPLICATION METHODS | 2017 |
|
RU2796539C2 |
| COMPOSITIONS AND METHODS OF TREATING ACUTE LUNG INJURY | 2019 |
|
RU2817906C2 |
| COMBINATION THERAPY | 2017 |
|
RU2754507C2 |
| COMPOSITIONS COMPRISING ANTIBODY TO CD38 AND CARFILZOMIB | 2014 |
|
RU2670127C2 |
| METHODS OF TREATING ALLERGIC DISEASES | 2011 |
|
RU2587061C2 |
| MODIFIED MONOCYTES/MACROPHAGES EXPRESSING CHIMERIC ANTIGEN RECEPTORS AND THEIR APPLICATIONS | 2016 |
|
RU2766690C2 |
